Efficacy of High-Dose Nebulized Interferon α 2b in Severe COVID-19 Pneumonia

Özet

The COVID-19 pandemic is progressing rapidly, sending the world into a great panic. Healthcare professionals haveresponded by embarking on a concerted search for therapies to cure and prevent COVID-19. Recently, interferon (IFN) has emerged as apotential therapy as it is associated with reducing lung inflammation and suppressing viral replication. This research paper assessed theefficacy of high-dose nebulized IFN α 2b in severe COVID-19 pneumonia.